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An actinobacterial strain VL-RK 09 having potential antimicrobial activities was isolated
from a mango orchard in Krishna District, Andhra Pradesh (India) and was identiﬁed as
Arthrobacter kerguelensis. The strain A. kerguelensis VL-RK 09 exhibited a broad spectrum of
in  vitro antimicrobial activity against bacteria and fungi. Production of bioactive metabo-
lites by the strain was the highest in modiﬁed yeast extract malt extract dextrose broth, as
compared to other media tested. Lactose (1%) and peptone (0.5%) were found to be the most
suitable carbon and nitrogen sources, respectively, for the optimum production of the bioac-
tive  metabolites. The maximum production of the bioactive metabolites was detected in the
culture medium with an initial pH of 7, in which the strain was incubated for ﬁve days at
30 ◦C under shaking conditions. Screening of secondary metabolites obtained from the cul-
ture  broth led to the isolation of a compound active against a wide variety of Gram-positive
and negative bacteria and fungi. The structure of the ﬁrst active fraction was  elucidated
using Fourier transform infrared spectroscopy, electrospray ionization mass spectrometry,
1H and 13C nuclear magnetic resonance spectroscopy. The compound was identiﬁed as S,S-
dipropyl carbonodithioate. This study is the ﬁrst report of the occurrence of this compound
in  the genus Arthrobacter.©  2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
s arti
otics continues to be of utmost importance in researchan  open acces
IntroductionThe natural products of microbial origin appear to be the
most promising source of future antibiotics.1,2 A search for
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new antibiotics or new microbial strains producing antibi-programs around the world because of the increases in
resistant pathogens and toxicity of some known antibiotics.
Nevertheless, there is an alarming scarcity of new antibiotics
Elsevier Editora Ltda. This is an open access article under the CC
.
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n the pharmaceutical industry. Therefore, to ensure the
vailability of effective drugs in the future, it is necessary
o improve the antimicrobial use patterns and to devise
trategies for the identiﬁcation of new antibiotics through
reviously unexplored targets.3,4 Development of novel drugs
ith a broad-spectrum mode of action against pathogens is
he need of the hour.
Actinobacteria are aerobic, Gram-positive and ﬁlamentous
n nature, which form asexual spores and mycelia and have
 high guanine and cytosine (GC content) in the DNA. They
re the most economically and biotechnologically valuable
rokaryotes with the unparalleled ability to produce bioactive
econdary metabolites, notably, antibiotics, antitumor agents,
mmunosuppressive agents, and enzymes. In view of their
xcellent track record in this regard, extensive attempts have
een made in the past 50 years to isolate actinobacteria from
errestrial sources for drug screening. In the present days,
n exploration of rare actinobacteria for bioactive metabo-
ite production has dramatically increased, particularly due
o their unique and diverse metabolic pathways against
ife-threatening resistant pathogens.5 A relatively low occur-
ence of non-streptomycete species as producers of secondary
etabolites is due to the absence of novel techniques for
he isolation of these strains from the environment. Another
roblem is their complicated preservation and cultivation
ethods, which frequently require speciﬁc and unusual con-
itions. These are the main reasons why these microbes
re considered rare organisms and why investigation and
anufacturing of their products are difﬁcult. Most isolates
ecovered on agar plates by conventional isolation techniques
ave been identiﬁed as species of Streptomyces, which are the
ominant actinobacteria present in soil.2,6–8
Rare actinobacteria are widely distributed in terrestrial
nd marine ecosystems having different environmental con-
itions such as soil type, pH, humus content and humic
cid characteristics of the soil.9 They are diverse and belong
o many  suborders, including Micrococcineae and to a
ariety of genera.10,11 The best-known genus of the fam-
ly Micrococcaceae is Arthrobacter, which includes aerobic,
atalase-positive, cocci or coryneform bacteria with lysine in
heir cell walls. Arthrobacter spp. exhibit great metabolic versa-
ility and are able to produce a number of valuable substances,
uch as amino acids, vitamins, enzymes, speciﬁc growth fac-
ors, and polysaccharides.12 However these organisms are not
ell explored as secondary metabolite producers, although
here have been reports of production of bioactive compounds
y some species.13–16 While rare actinobacteria may provide
ncreased chances of discovering novel structures, their genet-
cs and physiology are poorly understood.
As a part of our ongoing research on rare actinobacteria, a
romising strain VL-RK 09, with a good antimicrobial poten-
ial was identiﬁed as Arthrobacter kerguelensis. The strain was
solated from a soil sample collected at a mango orchard in
issannapet, Krishna District, Andhra Pradesh (India), and its
NA sequence was deposited to Genbank under accession
umber KJ787652. Since the components of culture media and
ultural conditions often inﬂuence the production of bioactive
etabolites by microorganisms.17–21 An attempt was made to
nhance the production of bioactive metabolites and to char-
cterize the metabolites of A. kerguelensis VL-RK 09. o g y 4 7 (2 0 1 6) 1030–1038 1031
Materials  and  methods
Chemicals
All solvents, reagents, and media components used in this
study were of extra-pure grade and procured from Merck
(Mumbai, India).
Strain  isolation
The strain, A. kerguelensis VL-RK 09, was isolated on yeast
extract-malt extract-dextrose (YMD) agar by a soil dilution
technique from a soil sample collected at a mango orchard in
Vissannapet, Andhra Pradesh, India. The medium consisted of
malt extract (1%), yeast extract (0.4%), dextrose (0.4%), CaCO3
(0.2%), and agar (2.0%), pH 7.0 ± 0.2. The strain was stored on
YMD  agar medium at 4 ◦C.22
Antimicrobial  proﬁle  of  bioactive  metabolites  produced  by
the strain
To study the antimicrobial proﬁle, a three-day-old culture of
the strain was cultivated in YMD  broth (seed medium) at 30 ◦C
for 24 h. Of the seed culture, 10% was transferred to the same
medium for mass fermentation. The fermentation process
was allowed to continue at 30 ◦C for eight days. The produc-
tion of bioactive metabolites was determined by measuring
diameters of inhibition zones against test microbes. Culture
ﬁltrates harvested at regular intervals were extracted with
ethyl acetate and evaporated to dry under vacuum at 35 ◦C.
The residue thus obtained was dissolved in dimethyl sulfox-
ide (DMSO) and tested for antimicrobial activity against test
bacteria such as Staphylococcus aureus (MTCC 3160), Bacillus
megaterium (NCIM 2187), Shigella ﬂexneri (MTCC 1457), Xan-
thomonas campestris (MTCC 2286), Proteus vulgaris (ATCC 6380),
Pseudomonas aeruginosa (ATCC 9027) and Escherichia coli (ATCC
35218) and fungus Candida albicans (MTCC 183) by an agar dif-
fusion assay.23
Media  optimization
Attempts were made to enhance the antimicrobial activity
by optimizing the culture conditions such as pH, temper-
ature, carbon sources, nitrogen sources and minerals. The
bioactive metabolite production was determined after ﬁve
days of incubation. Fermentation was carried out in 100 mL
of media in 250-mL Erlenmeyer ﬂasks with constant shaking
at 180 rpm. The effect of initial pH on bioactive metabolite
production by the strain was determined by adjusting pH of
the production medium in the range from 4 to 10. The opti-
mal  pH achieved at this step was used for further study.24
Similarly, the optimum temperature was determined by incu-
bating the strain at temperatures ranging from 20 to 40 ◦C,
while maintaining all other conditions at optimum levels.25
Carbon sources such as maltose, lactose, fructose, galactose,
sucrose, glucose, starch, cellulose, mannitol, and sorbitol were
supplemented separately at a 1% concentration into the fer-
mentation medium.26 The effect of varying concentrations
(0.5–4%) of the best carbon source on bioactive metabolite
c r o b1032  b r a z i l i a n j o u r n a l o f m i 
production was also investigated. Similarly, various nitrogen
sources, such as peptone, methionine, tryptophan, sodium
nitrate, proline, leucine, tyrosine, valine, aspartic acid, urea,
yeast extract, and arginine were individually supplemented
at 0.4% into the fermentation medium. Further, the impact of
different concentrations (0.1–1.5%) of the optimum nitrogen
source was studied to enhance the production of antimicro-
bial metabolites.27 To evaluate the effect of mineral salts, the
optimized medium containing the superior carbon and nitro-
gen source was supplemented separately with various mineral
supplements, such as K2HPO4, KH2PO4, KCl, MgSO4, FeSO4,
MnCl2, and NaCl at a concentration of 0.05% (w/v).28
Extraction  of  the  metabolite  and  antimicrobial  activity
assay
The strain A. kerguelensis VL-RK 09 was grown under opti-
mized conditions for ﬁve days. The culture broth was obtained
by centrifugation at 6000 rpm for 20 min, then extracted with
ethyl acetate, and dried in a rotary evaporator at 40 ◦C to
obtain a crude extract. The antimicrobial metabolites pro-
duced by the strain were tested by an-agar well diffusion
assay against bacteria, including S. aureus, B. megaterium, S.
ﬂexneri, X. campestris,  P. vulgaris, P .aeruginosa, E. coli,  Salmonella
typhi, Vibrio cholera and Streptococcus mutans (MTCC 497), grown
overnight at 37 ◦C, C. albicans (ATCC 10231), Aspergillus niger,
A. ﬂavus,  Fusarium solani,  F. oxysporum (MTCC 3075), Penicillium
citrinum and Alternaria sp. were used as test fungi.
Puriﬁcation  of  the  antimicrobial  compound
A seed culture (10%, v/v) prepared by culturing A. kergue-
lensis VL-RK 09 in ISP-2 (International Sterptomyces Project)
medium was transferred to fermentation broth contain-
ing malt extract- (1%), lactose (1%), peptone (0.5%), K2HPO4
(0.05%), and CaCO3 (0.2%), with pH adjusted to 7.0. A total of 40
conical ﬂasks of 2-L capacity containing 1 L of the broth, were
inoculated and incubated on a rotary shaker (180 rpm) at 30 ◦C
for 120 h under optimized conditions. The culture broth (40 L)
obtained after ﬁltration was extracted twice with ethyl acetate
and concentrated under reduced pressure to yield a crude
extract (4.2 g), which was then subjected to silica gel column
(80 × 2.5 cm)  chromatography. The separation of the crude
extract was conducted by gradient elution with hexane/ethyl
acetate. The eluent was run over the column, and small vol-
umes of the eluate collected in test tubes were analyzed by
thin-layer chromatography (TLC) using silica gel plates and a
hexane/ethyl acetate solvent system. Compounds with iden-
tical retention factors (Rf) were combined and assayed for
antimicrobial activity against Gram-positive (B. megaterium)
and Gram-negative (E. coli) bacteria and the yeast (C. albicans)
using an agar plate diffusion assay.23 Among the fractions, the
ﬁrst active fraction (200 mg)  with good antimicrobial activity
was re-chromatographed on a silicagel column using hex-
ane/ethyl acetate (80:20) as an eluting solvent system to obtain
30 mg  of a pure compound (S1), which was selected for further
studies. The structure of the active fraction was deduced by
Fourier transform infrared spectroscopy (FT-IR), electrospray i o l o g y 4 7 (2 0 1 6) 1030–1038
ionization mass spectrometry (ESI-MS) and 1H and 13C nuclear
magnetic resonance spectroscopy (NMR) spectroscopy.
Biological  assays
Minimum  inhibitory  concentration
The antimicrobial spectra of the bioactive compound pro-
duced by the strain were determined in terms of minimum
inhibitory concentration (MIC) by using the agar plate diffu-
sion assay. The MIC  of active compound S1 was investigated
in comparison with tetracycline. Muller-Hinton agar and
Sabouraud dextrose agar media were prepared to grow the
bacteria and fungi, respectively. Dilutions of the test com-
pound S1 and the reference drug were prepared in DMSO at
concentrations ranging from 0 to 1000 g/mL and were added
to cups. The Petri dishes were inoculated with 1.5 × 104 colony
forming units (cfu/mL) and incubated at 37 ◦C for 24–48 h
for bacteria and 48–72 h at 28 ◦C for fungi. The lowest con-
centration of the bioactive compounds exhibiting signiﬁcant
antimicrobial activity against the test microbes was taken as
the MIC of the compound.
The MICs of the bioactive compound (S1) produced by the
strain was determined against several pathogenic bacteria and
fungi. S. aureus,  B. megaterium, B. subtilis (ATCC 6633), B. cereus
(MTCC 430), Serratia marcescens (MTCC 1457), X. campestris,  P.
vulgaris (MTCC 7299), P. aeruginosa (ATCC 9027), E. coli (ATCC
35218), Enterococcus faecalis (MTCC 439), S. mutans, Lactobacillus
casei (MTCC 1423), and L. acidophilus (MTCC 495) were used for
the antibacterial assay. C. albicans, A. niger, A. ﬂavus,  F. solani,
F. oxysporum and P. citrinum were used for testing antifungal
activity.
Statistical  analysis
The results of bioactive metabolite production by A. kergue-
lensis under different cultural conditions were statistically
analyzed with one-way analysis of variance (ANOVA).
Results  and  discussion
Antimicrobial  proﬁle  of  bioactive  metabolites  produced  by
the strain
The growth pattern of A. kerguelensis VL-RK 09 was stud-
ied in YMD broth. The stationary phase of the strain lasted
from 96 to 120 h of incubation (Fig. 1). The crude extract
obtained from a ﬁve-day-old culture exhibited high antimi-
crobial activity against the test microorganisms. A previous
report demonstrated high antimicrobial activity of crude
extracts of a ﬁve-day-old culture of Rhodococcus erythropo-
lis VL-RK 05.29 Naragani et al.30 reported the presence of
antimicrobial compounds in ﬁve-day-old culture extracts of
Streptomyces violaceoruber VLK-4.
Inﬂuence  of  culture  media  on  antimicrobial  activityAntimicrobial activity of the strain was studied by grow-
ing it in different culture media (Fig. 2). ISP-2 supported
the production of bioactive compounds with the highest
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levels of bioactive metabolites at an incubation temperature
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Effect  of  carbon  and  nitrogen  sources  on  antimicrobial
activity
To ﬁnd a suitable carbon source for secondary metabolite pro-
duction by the strain, dextrose in YMD broth was replaced
with various carbon sources supplemented at a concentra-
tion of 0.4%. The effects of carbon sources on production of
bioactive metabolites by A. kerguelensis VL-RK 09 are presented
in Fig. 5. Since lactose supported a high yield of bioactive
metabolites, different concentrations of lactose (0.5–4%) were
tested to determine the optimal concentration. Lactose at a
concentration of 1% supported the highest yield of bioactive
metabolites (Fig. 6).
These results are comparable with those obtained for Strep-
tomyces hygroscopicus strains AK-111-81 and CH-7, which uti-
lized lactose as a carbon source for antibiotic production.37,38
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Table 1 – Antimicrobial activity of Arthrobacter
kerguelensis VL-RK 09 under optimized culturing
conditions.
Zone of inhibition (mm)
Test organisms (bacteria)
1 Staphylococcus aureus 34
2 Bacillus megaterium 39
3 Shigella ﬂexneri 27
4 Xanthomonas campestris 32
5 Proteus vulgaris 30
6 Pseudomonas aeruginosa 33
7 Escherichia coli 24
8 Corynebacterium diphtheriae 26
9 Salmonella typhi 18
10 Streptococcus mutans 25
11 Vibrio cholerae 24
Fungi
12 Candida albicans 29
13 Aspergillus niger 25
14 A.ﬂavus 22
15 Fusarium solani 21
16 F. oxysporum 20
17 Penicillium citrinum 18
crobial metabolites by a terrestrial isolate, A. kerguelensis
VL-RK 09, isolated from a mango orchard.
O
SS18 Alternaria sp. 21
CaCO3 (0.2%), pH 7.0 ± 0.2, temperature 30 ◦C, and the incuba-
tion period of ﬁve days, showed strong antimicrobial activity
against bacteria and fungi (Table 1). Among the bacteria tested,
B. megaterium, S. aureus,  P. aeruginosa,  X. campestris,  and P.
vulgaris appeared to be highly sensitive to the metabolites
produced by the strain.
The  isolation,  puriﬁcation,  and  structural  elucidation  of  an
active metabolite
The culture ﬁltrate obtained after 120 h of fermentation was
extracted with ethyl acetate and concentrated in vacuum to
yield a dark brown residue, which was then subjected to silica
gel column chromatography using a gradient solvent system
of hexane/ethyl acetate.el.
Among the fractions, the ﬁrst active fraction (200 mg) with
good antimicrobial activity was re-chromatographed on a sil-
ica gel column using hexane: ethyl acetate (80:20) as the
eluting solvent system to obtain a pure compound (30 mg).
The structure of the puriﬁed compound S1 was elucidated and
characterized by FT-IR, mass, and NMR spectroscopy.
Compound S1 was isolated as a yellow-orange liquid, sol-
uble in CHCl3, methanol, dichloromethane, and DMSO. The IR
absorption maximums (Vmax) at 2924, 2856, 1739, 1629, 1380
and 1095 cm−1 suggested the presence of carbonyl functional
groups (Fig. S1). In ESI–MS, the compound showed molecular
ions at m/z 178, inferring the molecular formula of C7H14OS2
(Fig. S2). The proton NMR of the compound displayed proton
signals at 2.33 (t, J = 7.3 Hz, 2H), 1.66 (q, J = 7.3, 7.47 Hz, 2H),
and 0.97 (t, J = 7.47 Hz, 3H) (Fig. S3). 13C NMR  depicted peaks
and showed signals at 180.12, 35.97, 17.73, and 13.34 (Fig. S4).
Based on these spectral data, the ﬁrst active compound S1 was
identiﬁed as S,S-dipropyl carbonodithioate (Fig. 10). This is the
ﬁrst report of the occurrence of this compound in the genus
Arthrobacter.
Arthrobacter is a common genus of soil bacteria, which are
metabolically versatile and produce different enzymes allow-
ing the bacteria to grow on a wide range of substrates. The
members of the genus are not well explored as secondary
metabolite producers although there had been reports of
production of bioactive compounds by some species. Antimi-
crobial metabolites have been studied in some aquatic and
polar strains of Arthrobacter.43,44 Hence, an attempt was  made
in the present study to evaluate the production of antimi-Fig. 10 – Molecular structure of S,S-dipropyl
carbonodithioate (S1).
b r a z i l i a n j o u r n a l o f m i c r o b i o l
Table 2 – MIC  of S,S-dipropyl carbonodithioate isolated
from Arthrobacter kerguelensis VL-RK 09 against different
pathogenic bacteria and fungi.
Test organisms MICa (g/mL)
S1 Positive controlb
Bacteria
Staphylococcus aureus 75 25
Streptococcus mutans 80 30
Bacillus subtilis 90 40
Lactobacillus casei 85 25
Lactobacillus acidophilus 90 25
Xanthomonas campestris 75 40
Bacillus megaterium 75 30
Bacillus cereus 90 30
Escherichia coli 90 25
Pseudomonas aeruginosa 70 40
Serratia marcescens 90 25
Proteus vulgaris 125 50
Enterococcus faecalis 150 25
Yeast
Candida albicans 150 50
Molds
Aspergillus niger 100 5
A. ﬂavus 75 10
Fusarium oxysporum 90 10
Fusarium solani 95 10
Penicillium citrinum 125 10
a MIC, minimum inhibitory concentration.
b Tetracycline against bacteria, Griseofulvin against yeast and Car-
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12. Li JQ, Tan BP, Mai KS, et al. Comparative study betweenbendazim against molds.
S1, S,S-dipropyl carbonodithioate.
iological  assay
he antimicrobial proﬁle of the bioactive compound based on
he MIC  values is shown in Table 2. B. megaterium was highly
ensitive to the compound, followed by S. aureus,  S. mutans,
. subtilis, and B. cereus among the Gram-positive bacteria. P.
eruginosa was highly sensitive to the compound followed by X.
ampestris,  E. coli,  S. marcesens,  P. vulgaris, and E. faecalis among
he Gram-negative bacteria.
Among the fungi tested, A. ﬂavus was found to be more
ensitive than the others. The MIC  values of S,S-dipropyl car-
onodithioate against the test bacteria and fungi varied from
5 to 150 g/mL.
onclusions
n the present study, a rare actinobacterium was isolated on
SP-2 agar medium as a predominant strain from soil collected
t a mango orchard. Screening of the strain for antagonistic
ctivity revealed its potential to inhibit several opportunistic
athogens in vitro. The strain was identiﬁed as A. kergue-
ensis by genomic analysis and designated as VL-RK 09. In
rder to improve the productivity of the strain, an optimiza-
ion of nutritional and physiological factors was carried out.
he strain exhibited high antimicrobial activity when grown
n an optimized culture medium (lactose, 1%; peptone, 0.5%;
2HPO4, 0.05%) at pH 7.0 and incubated at 30 ◦C for 120 h. An o g y 4 7 (2 0 1 6) 1030–1038 1037
attempt was also made to characterize antimicrobial metabo-
lites by culturing the strain in a large volume of the medium.
Extraction, followed by bioactivity-guided isolation and puriﬁ-
cation of a crude ethylacetate extract, revealed the presence
of S,S-dipropyl carbonodithioate. This is the ﬁrst report on
S,S-dipropyl carbonodithioate isolated from A. kerguelensis VL-
RK 09.
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